Target intelligence / Profile preview

Bacterial cell membrane phospholipids and lipid A phosphates in lipopolysaccharide (LPS/Lipid A phosphates)

Target
LPS/Lipid A phosphates
Molecular classification
Other, Lipid, Bacterial cell wall component
01

Overview

Bacterial cell membrane phospholipids and lipid A phosphates in lipopolysaccharide (LPS) are essential structural elements of the Gram-negative bacterial outer membrane. Lipid A, the lipid component of LPS, acts as a hydrophobic anchor and is the primary moiety responsible for the endotoxic shock associated with Gram-negative sepsis by activating the TLR4 signaling pathway (Raetz & Whitfield, 2002, Annual Review of Biochemistry). The negatively charged phosphate groups on lipid A and surrounding phospholipids are crucial for membrane stability, as they bind divalent cations like magnesium and calcium to cross-link adjacent LPS molecules (Trimble et al., 2006, Cold Spring Harbor Perspectives in Medicine). This anionic surface serves as the specific target for cationic polypeptide antibiotics, such as polymyxins, which bind to the phosphate groups and displace the stabilizing cations (Poirel et al., 2017, Clinical Microbiology Reviews). This interaction leads to a detergent-like disruption of the outer membrane, increased permeability, and subsequent cell death. While highly effective against multi-drug resistant pathogens, targeting these components is associated with significant clinical challenges, including nephrotoxicity and the emergence of resistance through enzymatic modification of the phosphate groups (Falagas & Kasiakou, 2005, Critical Care).

Other names
Lipid AEndotoxinLipopolysaccharide phosphatesGram-negative outer membrane phospholipids
02

Mechanism of action

Binding to negatively charged phosphate groups and displacement of divalent cations (Mg2+ and Ca2+), leading to outer membrane disruption and increased cell permeability.

03

Biological functions

OtherImmune responseStructural integrityPermeability barrier
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityNeurotoxicityAntibiotic resistance via lipid A modification (e.g., mcr-1 gene)
06

Interacting drugs

Polymyxin B

2 more in the full profile.

07

Biomarkers

Endotoxin levelsProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Bacterial cell membrane phospholipids and lipid A phosphates in lipopolysaccharide (LPS/Lipid A phosphates).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell membrane phospholipids and lipid A phosphates in lipopolysaccharide (LPS/Lipid A phosphates).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call